Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06947187 · ClinicalTrials.gov registry record · NA
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
A NA study of Misinformation, sponsored by University of California, Berkeley.
- Recruiting
- Registry status
- NA
- Development phase
- 472
- Enrollment target
- 1
- Study location
NCT06947187: Recruiting NA study of Misinformation, sponsored by University of California, Berkeley.
NCT06947187 is a NA study of Misinformation that is actively recruiting participants, run by University of California, Berkeley. The registered enrollment target is 472 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06947187, a NA study of Misinformation, is actively recruiting participants, sponsored by University of California, Berkeley.
- RECRUITING
- Registry status
- NA
- Development phase
- 472 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to understand how well a culturally-specific "prebunking" video can improve vaccine information literacy and vaccine confidence among individuals in the Nusantara sociocultural sphere. The investigators hypothesize the individuals who watch the co-created "prebunking" intervention video will have improved vaccine literacy skills and vaccine confidence compared to individuals who watch a video about safe medication disposal.
Primary Outcome
The percent of social media posts that the participant correctly identifies as misinformation
Conditions Studied
Interventions
- OTHER Pre-bunking video
- OTHER Video on safe disposal of medication
Study Locations (1)
California
- University of California, Berkeley - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 472 participants |
| Start Date | 2024-12-28 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT06947187 shows while recruiting
NCT06947187 is an interventional study that assigns participants to a tested intervention. The registered 472 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Misinformation appearing as the primary indexed condition, and to 2 interventions - of which Pre-bunking video is the first listed.
NCT06947187 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06947187 about?
NCT06947187 is a clinical study titled "Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere". The goal of this clinical trial is to understand how well a culturally-specific "prebunking" video can improve vaccine information literacy and vaccine confidence among individuals in the Nusantara sociocultural sphere. The investigators hypothesize the individuals who watch the co-created "prebunki...
What is the current status of trial NCT06947187?
This trial is currently recruiting. It is a NA study. The enrollment target is 472 participants. The study started on 2024-12-28. Estimated completion is 2026-06-01.
What conditions does trial NCT06947187 study?
This clinical trial studies the following conditions: Misinformation.
What interventions are being tested in trial NCT06947187?
The interventions under investigation include: Pre-bunking video (OTHER), Video on safe disposal of medication (OTHER).
Who is sponsoring clinical trial NCT06947187?
This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06947187 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06947187's enrollment target sits among peer trials
472 220th of 2000 higher than 1,781 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
- NCT07199517 · 472 participants · NA
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
- NCT07225881 · 472 participants · NA
Eatwell Clinical Trial (R01)
- NCT03010150 · 471 participants
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI